These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12602460)

  • 1. FOSIDIAL: a randomised placebo controlled trial of the effects of fosinopril on cardiovascular morbidity and mortality in haemodialysis patients. Study design and patients' baseline characteristics.
    Zannad F; Kessler M; Grünfeld JP; Thuilliez C;
    Fundam Clin Pharmacol; 2002 Oct; 16(5):353-60. PubMed ID: 12602460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visit-to-visit blood pressure variability is a strong predictor of cardiovascular events in hemodialysis: insights from FOSIDIAL.
    Rossignol P; Cridlig J; Lehert P; Kessler M; Zannad F
    Hypertension; 2012 Aug; 60(2):339-46. PubMed ID: 22777936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fosinopril reduces left ventricular mass in untreated hypertensive patients: a controlled trial.
    Cheung BM; Lau CP
    Br J Clin Pharmacol; 1999 Feb; 47(2):179-87. PubMed ID: 10190653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy and tolerability of fosinopril in Chinese type 2 diabetic patients with moderate renal insufficiency.
    Tong PC; Ko GT; Chan WB; Ma RC; So WY; Lo MK; Lee KF; Ozaki R; Chow CC; Cockram CS; Chan JC
    Diabetes Obes Metab; 2006 May; 8(3):342-7. PubMed ID: 16634995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies.
    Zannad F; Kessler M; Lehert P; Grünfeld JP; Thuilliez C; Leizorovicz A; Lechat P
    Kidney Int; 2006 Oct; 70(7):1318-24. PubMed ID: 16871247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of fosinopril on progression of the asymptomatic carotid atherosclerosis and left ventricular hypertrophy in hypertensive patients].
    Tasić IS; Mijalković D; Djordjević D; Lović B; Janković D; Miladinović-Tasić N; Lović M
    Srp Arh Celok Lek; 2006; 134(3-4):106-13. PubMed ID: 16915750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fosinopril attenuates clinical deterioration and improves exercise tolerance in patients with heart failure. Fosinopril Efficacy/Safety Trial (FEST) Study Group.
    Erhardt L; MacLean A; Ilgenfritz J; Gelperin K; Blumenthal M
    Eur Heart J; 1995 Dec; 16(12):1892-9. PubMed ID: 8682023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of cardiovascular events in patients with end-stage renal disease: an analysis from the Fosinopril in dialysis study.
    Kessler M; Zannad F; Lehert P; Grünfeld JP; Thuilliez C; Leizorovicz A; Lechat P;
    Nephrol Dial Transplant; 2007 Dec; 22(12):3573-9. PubMed ID: 17611249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hyperkalemia in hypertensive patients undergoing regular hemodialysis during enalapril and fosinopril therapy].
    Dimković N; Djordjević T; Popović J; Dimković S; Tirmenstajn-Janković B; Zivanović M; Bobanović-Hasković J
    Srp Arh Celok Lek; 2006; 134(1-2):44-8. PubMed ID: 16850577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of efficacy and safety between benidipine and hydrochlorothiazide in fosinopril-treated hypertensive patients with chronic kidney disease: protocol for a randomised controlled trial.
    Xue C; Zhou C; Yang B; Lv J; Dai B; Yu S; Wang Y; Zhao G; Mei C
    BMJ Open; 2017 Feb; 7(2):e013672. PubMed ID: 28237959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of fosinopril and enalapril in patients with mild to moderate chronic heart failure. Fosinopril in Heart Failure Study Investigators.
    Zannad F; Chati Z; Guest M; Plat F
    Am Heart J; 1998 Oct; 136(4 Pt 1):672-80. PubMed ID: 9778071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale, design, and baseline characteristics of a trial of prevention of cardiovascular and renal disease with fosinopril and pravastatin in nonhypertensive, nonhypercholesterolemic subjects with microalbuminuria (the Prevention of REnal and Vascular ENdstage Disease Intervention Trial [PREVEND IT]).
    Diercks GF; Janssen WM; van Boven AJ; Bak AA; de Jong PE; Crijns HJ; van Gilst WH
    Am J Cardiol; 2000 Sep; 86(6):635-8. PubMed ID: 10980214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of ACE inhibitor therapy on left ventricular myocardial mass and diastolic filling in previously untreated hypertensive patients: a cine MRI study.
    Hoffmann U; Globits S; Stefenelli T; Loewe C; Kostner K; Frank H
    J Magn Reson Imaging; 2001 Jul; 14(1):16-22. PubMed ID: 11436209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of imidapril on left ventricular mass in chronic hemodialysis patients.
    Matsumoto N; Ishimitsu T; Okamura A; Seta H; Takahashi M; Matsuoka H
    Hypertens Res; 2006 Apr; 29(4):253-60. PubMed ID: 16778332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction (TELMAR) as assessed by magnetic resonance imaging in patients with mild-to-moderate hypertension--a prospective, randomised, double-blind comparison of telmisartan with metoprolol over a period of six months rationale and study design.
    Friedrich MG; Dahlöf B; Sechtem U; Unger T; Knecht M; Dietz R;
    J Renin Angiotensin Aldosterone Syst; 2003 Dec; 4(4):234-43. PubMed ID: 14689371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diverse effects of chronic treatment with losartan, fosinopril, and amlodipine on apoptosis, angiotensin II in the left ventricle of hypertensive rats.
    Yu G; Liang X; Xie X; Su M; Zhao S
    Int J Cardiol; 2001 Dec; 81(2-3):123-9; discussion 129-30. PubMed ID: 11744126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-converting enzyme inhibition and novel cardiovascular risk biomarkers: results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors (TRAIN) study.
    Cesari M; Kritchevsky SB; Atkinson HH; Penninx BW; Di Bari M; Tracy RP; Pahor M
    Am Heart J; 2009 Feb; 157(2):334.e1-8. PubMed ID: 19185642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria.
    Asselbergs FW; Diercks GF; Hillege HL; van Boven AJ; Janssen WM; Voors AA; de Zeeuw D; de Jong PE; van Veldhuisen DJ; van Gilst WH;
    Circulation; 2004 Nov; 110(18):2809-16. PubMed ID: 15492322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A random comparison of fosinopril and nifedipine GITS in patients with primary renal disease.
    Marin R; Ruilope LM; Aljama P; Aranda P; Segura J; Diez J;
    J Hypertens; 2001 Oct; 19(10):1871-6. PubMed ID: 11593109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy of hypertension in the elderly: Fosinopril in Old Patients Study (FOPS)].
    Koch J; Greminger P; Simeon-Dubach D
    Praxis (Bern 1994); 1997 Nov; 86(45):1779-84. PubMed ID: 9446181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.